150 related articles for article (PubMed ID: 28260622)
1. Group B adenovirus enadenotucirev infects polarised colorectal cancer cells efficiently from the basolateral surface expected to be encountered during intravenous delivery to treat disseminated cancer.
Chia SL; Lei J; Ferguson DJP; Dyer A; Fisher KD; Seymour LW
Virology; 2017 May; 505():162-171. PubMed ID: 28260622
[TBL] [Abstract][Full Text] [Related]
2. Expression of human CD46 and trans-complementation by murine adenovirus 1 fails to allow productive infection by a group B oncolytic adenovirus in murine cancer cells.
Lei J; Jacobus EJ; Taverner WK; Fisher KD; Hemmi S; West K; Slater L; Lilley F; Brown A; Champion B; Duffy MR; Seymour LW
J Immunother Cancer; 2018 Jun; 6(1):55. PubMed ID: 29898782
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus Receptor Expression in Cancer and Its Multifaceted Role in Oncolytic Adenovirus Therapy.
Hensen LCM; Hoeben RC; Bots STF
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957644
[TBL] [Abstract][Full Text] [Related]
4. Actin-resistant DNAse I Expression From Oncolytic Adenovirus Enadenotucirev Enhances Its Intratumoral Spread and Reduces Tumor Growth.
Tedcastle A; Illingworth S; Brown A; Seymour LW; Fisher KD
Mol Ther; 2016 Apr; 24(4):796-804. PubMed ID: 26708004
[TBL] [Abstract][Full Text] [Related]
5. Oncolytic adenovirus expressing bispecific antibody targets T-cell cytotoxicity in cancer biopsies.
Freedman JD; Hagel J; Scott EM; Psallidas I; Gupta A; Spiers L; Miller P; Kanellakis N; Ashfield R; Fisher KD; Duffy MR; Seymour LW
EMBO Mol Med; 2017 Aug; 9(8):1067-1087. PubMed ID: 28634161
[TBL] [Abstract][Full Text] [Related]
6. Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection.
Garcia-Carbonero R; Salazar R; Duran I; Osman-Garcia I; Paz-Ares L; Bozada JM; Boni V; Blanc C; Seymour L; Beadle J; Alvis S; Champion B; Calvo E; Fisher K
J Immunother Cancer; 2017 Sep; 5(1):71. PubMed ID: 28923104
[TBL] [Abstract][Full Text] [Related]
7. Studies on the Interaction of Tumor-Derived HD5 Alpha Defensins with Adenoviruses and Implications for Oncolytic Adenovirus Therapy.
Vragniau C; Hübner JM; Beidler P; Gil S; Saydaminova K; Lu ZZ; Yumul R; Wang H; Richter M; Sova P; Drescher C; Fender P; Lieber A
J Virol; 2017 Mar; 91(6):. PubMed ID: 28077642
[TBL] [Abstract][Full Text] [Related]
8. An oncolytic adenovirus defective in pRb-binding (dl922-947) can efficiently eliminate pancreatic cancer cells and tumors in vivo in combination with 5-FU or gemcitabine.
Bhattacharyya M; Francis J; Eddouadi A; Lemoine NR; Halldén G
Cancer Gene Ther; 2011 Oct; 18(10):734-43. PubMed ID: 21836633
[TBL] [Abstract][Full Text] [Related]
9. Characterization of human adenovirus serotypes 5, 6, 11, and 35 as anticancer agents.
Shashkova EV; May SM; Barry MA
Virology; 2009 Nov; 394(2):311-20. PubMed ID: 19765790
[TBL] [Abstract][Full Text] [Related]
10. A novel bladder cancer - specific oncolytic adenovirus by CD46 and its effect combined with cisplatin against cancer cells of CAR negative expression.
Cao W; Tian J; Li C; Gao Y; Liu X; Lu J; Wang Y; Wang Z; Svatek RS; Rodriguez R
Virol J; 2017 Aug; 14(1):149. PubMed ID: 28789701
[TBL] [Abstract][Full Text] [Related]
11. Retargeting the coxsackievirus and adenovirus receptor to the apical surface of polarized epithelial cells reveals the glycocalyx as a barrier to adenovirus-mediated gene transfer.
Pickles RJ; Fahrner JA; Petrella JM; Boucher RC; Bergelson JM
J Virol; 2000 Jul; 74(13):6050-7. PubMed ID: 10846088
[TBL] [Abstract][Full Text] [Related]
12. Virotherapy using a novel chimeric oncolytic adenovirus prolongs survival in a human pancreatic cancer xenograft model.
Chu QD; Sun G; Pope M; Luraguiz N; Curiel DT; Kim R; Li BD; Mathis JM
Surgery; 2012 Sep; 152(3):441-8. PubMed ID: 22853858
[TBL] [Abstract][Full Text] [Related]
13. Basolateral localization of fiber receptors limits adenovirus infection from the apical surface of airway epithelia.
Walters RW; Grunst T; Bergelson JM; Finberg RW; Welsh MJ; Zabner J
J Biol Chem; 1999 Apr; 274(15):10219-26. PubMed ID: 10187807
[TBL] [Abstract][Full Text] [Related]
14. Herpes virus infection of RPE and MDCK cells: polarity of infection.
Topp KS; Rothman AL; Lavail JH
Exp Eye Res; 1997 Mar; 64(3):343-54. PubMed ID: 9196385
[TBL] [Abstract][Full Text] [Related]
15. Infection and killing of multiple myeloma by adenoviruses.
Senac JS; Doronin K; Russell SJ; Jelinek DF; Greipp PR; Barry MA
Hum Gene Ther; 2010 Feb; 21(2):179-90. PubMed ID: 19788385
[TBL] [Abstract][Full Text] [Related]
16. Access to nectin favors herpes simplex virus infection at the apical surface of polarized human epithelial cells.
Galen B; Cheshenko N; Tuyama A; Ramratnam B; Herold BC
J Virol; 2006 Dec; 80(24):12209-18. PubMed ID: 17005657
[TBL] [Abstract][Full Text] [Related]
17. In vitro primary cell culture as a physiologically relevant method for preclinical testing of human oncolytic adenovirus.
Adamson RE; Frazier AA; Evans H; Chambers KF; Schenk E; Essand M; Birnie R; Mitry RR; Dhawan A; Maitland NJ
Hum Gene Ther; 2012 Feb; 23(2):218-30. PubMed ID: 21823897
[TBL] [Abstract][Full Text] [Related]
18. Development of a versatile oncolytic virus platform for local intra-tumoural expression of therapeutic transgenes.
Marino N; Illingworth S; Kodialbail P; Patel A; Calderon H; Lear R; Fisher KD; Champion BR; Brown ACN
PLoS One; 2017; 12(5):e0177810. PubMed ID: 28542292
[TBL] [Abstract][Full Text] [Related]
19. Heparan Sulfate Binding Coxsackievirus B3 Strain PD: A Novel Avirulent Oncolytic Agent Against Human Colorectal Carcinoma.
Hazini A; Pryshliak M; Brückner V; Klingel K; Sauter M; Pinkert S; Kurreck J; Fechner H
Hum Gene Ther; 2018 Nov; 29(11):1301-1314. PubMed ID: 29739251
[TBL] [Abstract][Full Text] [Related]
20. Species D adenoviruses as oncolytics against B-cell cancers.
Chen CY; Senac JS; Weaver EA; May SM; Jelinek DF; Greipp P; Witzig T; Barry MA
Clin Cancer Res; 2011 Nov; 17(21):6712-22. PubMed ID: 21890454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
